# Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.

> **NCT05027646** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin, Inc.** · enrollment: 134 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Sancuso - Part 1
- **DRUG:** Sancuso - Part 2

## Key facts

- **NCT ID:** NCT05027646
- **Lead sponsor:** Kyowa Kirin, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-06
- **Primary completion:** 2021-12-22
- **Final completion:** 2022-01-19
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2024-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027646, "Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05027646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*